Basic Information
Category
Subcategory & Sub-subcategory
/
Trade Type
Sell
Product Name
Oxyplan
Details
Substance
Manufacturer(s)
- -
Registered Market
Specifications
- Dosage Form: Powder reconstituted as suspension oral
- Packaging: Box 1 vial x 15 g, powder for reconstitution as 60 mL suspension
- Standards: In-house standard
- Shelf Life: 36 month
Documents
Drug Marketing Authorization Number
Document No.: 893110209025
Issue Date: Jun 2, 2025
Expiry Date: Jun 2, 2030
Note: 286/QĐ-QLD | 217
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment